Page 2 - நாசி News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from நாசி. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In நாசி Today - Breaking & Trending Today

Saving lives and supporting recovery from addiction


Saving lives and supporting recovery from addiction
Alberta’s government is opening more medical detox beds and offering nasal naloxone kits in Edmonton as part of its ongoing work to save lives and increase access to recovery supports.
Some parts of this page will not display.
JavaScript is not available in this browser or may be turned off.
With $2.1 million from the government over three years, Edmonton’s George Spady Society now has 35 medical detox beds.
Another $1.5 million from the provincial government is supporting a pilot project to provide Albertans in the Edmonton area with publicly funded nasal naloxone kits. The project is being led by the George Spady Society, in collaboration with Alberta Health Services, Edmonton Police Services and other community partners. ....

Edmonton Police Service , George Spady Society , Edmonton George Spady Society , George Spady Centre , Alberta Health Services , Edmonton Police Services , Virtual Opioid Dependency Program , George Spady , Addiction Helpline , News Release , June 2021 , Un 2021 , எட்மண்டன் போலீஸ் சேவை , ஜார்ஜ் ஸ்பேடி சமூகம் , ஜார்ஜ் ஸ்பேடி மையம் , ஆல்பர்ட்டா ஆரோக்கியம் சேவைகள் , எட்மண்டன் போலீஸ் சேவைகள் , மெய்நிகர் ஓபியாய்டு சார்பு ப்ரோக்ர்யாம் , ஜார்ஜ் ஸ்பேடி , செய்தி வெளியீடு ,

Russia may register nasal COVID-19 vaccine in 2022 – developer

MOSCOW. KAZINFORM - Russia may register a nasal vaccine against COVID-19 developed by the Gamaleya Research Center for Epidemiology and Microbiology in 2022, if the clinical trials planned for 2021-2022 are successful, head of the center Alexander Ginzburg told TASS. ....

Alexander Ginzburg , Gamaleya Research Center , Covid 19 ,

Initiated clinical trial with novel nasal spray codenamed APR-AOS2020 [...]


12 maggio 2021 16:52
Fonte: Adnkronos
#salute-e-benessere
Product recently cleared in EU as Class III medical device
BALERNA, Switzerland, May 12, 2021 /PRNewswire/ APR Applied Pharma Research s.a. (APR), a leader in the development of pharmaceutical drug delivery technologies and systems and innovative products derived thereof, today announced the start of a pivotal clinical trial to assess the efficacy of its product temporarily codenamed APR-AOS2020, a Class III medical device, in the treatment of COVID-19 patients showing mild symptoms. The study is being conducted by the Hygiene Unit of IRCCS Policlinico San Martino Hospital in Genoa, Italy and coordinated by Prof. Giancarlo Icardi as lead investigator. The study is planned to enroll a total of 57 COVID-19 patients who show mild symptoms of the disease and is evaluating the efficacy and safety of the spray product in reducing viral load in the upper respiratory airways in recently infected individuals. Resul ....

United States , Switzerland General , Paolo Galfetti , Professorgiancarlo Icardi , Giancarlo Icardi , Pharma Research , Hygiene Unit , San Martino Hospital , Antiviral Research , Utah State University , Apr Aos2020 , ஒன்றுபட்டது மாநிலங்களில் , சுவிட்சர்லாந்து ஜநரல் , பார்மா ஆராய்ச்சி , சுகாதாரம் அலகு , சான் மார்டினோ மருத்துவமனை , உட்டா நிலை பல்கலைக்கழகம் ,